Whedy Wang's Title
Whedy Wang serves as the Senior Vice President of Biometrics, a role that underscores his extensive expertise and leadership in the biopharmaceutical industry. In this capacity, Wang oversees all aspects of biometrics, ensuring the integrity and accuracy of clinical data, which is critical for regulatory submissions and the successful commercialization of pharmaceutical products.
Whedy Wang's Education and Expertise
Whedy Wang holds a Ph.D. in biostatistics and an MPH in epidemiology from the University of Michigan, Ann Arbor, providing him with a robust foundation in statistical analysis and public health. His expertise spans biostatistics, clinical data management, clinical and statistical programming, and medical writing. This strong educational background has been instrumental in his ability to lead complex biostatistical projects and contribute to the advancement of medical research.
Whedy Wang's Experience
With over 25 years of experience in the biopharmaceutical industry, Whedy Wang has held significant leadership roles at prominent companies such as Alector, Theravance Biopharma, Orexigen, and Gilead Sciences Palo Alto (formerly CV Therapeutics). His strategic leadership in these roles has been pivotal in navigating regulatory submissions, advisory committee meetings, and the commercialization of six compounds. Wang has also demonstrated proficiency in business development, securing successful collaborations and substantial royalty financing deals.
Whedy Wang's Achievements
Whedy Wang has an impressive track record of achievements in the biopharmaceutical sector. He has successfully navigated eight regulatory submissions and three advisory committee meetings, contributing to the registration and commercialization of six compounds, including the global projects Lexiscan®️ and Ranexa®️. Additionally, Wang co-founded the Bay Area Biotech-Pharma Statistics Workshop, showcasing his commitment to advancing the field of biostatistics and fostering professional development within the industry.
Whedy Wang's Contributions to Biopharmaceuticals
Throughout his career, Whedy Wang has made significant contributions to the biopharmaceutical industry. His leadership in biometrics has ensured the accuracy and integrity of clinical data, which is vital for the development and commercialization of new drugs. Wang's expertise in business development has also facilitated successful collaborations and license agreements, further advancing the industry and bringing innovative treatments to market.